- Home
- PGEN vs MVBF Comparison
PGEN vs MVBF Comparison
Compare PGEN & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- MVBF
- Stock Information
- Founded
- PGEN 1998
- MVBF 1997
- Country
- PGEN United States
- MVBF United States
- Employees
- PGEN N/A
- MVBF N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- MVBF Major Banks
- Sector
- PGEN Health Care
- MVBF Finance
- Exchange
- PGEN Nasdaq
- MVBF Nasdaq
- Market Cap
- PGEN 493.0M
- MVBF 333.7M
- IPO Year
- PGEN N/A
- MVBF N/A
- Fundamental
- Price
- PGEN $3.89
- MVBF $26.52
- Analyst Decision
- PGEN Buy
- MVBF Strong Buy
- Analyst Count
- PGEN 5
- MVBF 5
- Target Price
- PGEN $7.50
- MVBF $26.60
- AVG Volume (30 Days)
- PGEN 4.5M
- MVBF 37.2K
- Earning Date
- PGEN 11-13-2025
- MVBF 10-29-2025
- Dividend Yield
- PGEN N/A
- MVBF 2.56%
- EPS Growth
- PGEN N/A
- MVBF 72.82
- EPS
- PGEN N/A
- MVBF 2.45
- Revenue
- PGEN $4,340,000.00
- MVBF $167,853,000.00
- Revenue This Year
- PGEN $249.10
- MVBF N/A
- Revenue Next Year
- PGEN $710.03
- MVBF $12.76
- P/E Ratio
- PGEN N/A
- MVBF $10.83
- Revenue Growth
- PGEN N/A
- MVBF 18.75
- 52 Week Low
- PGEN $0.65
- MVBF $15.59
- 52 Week High
- PGEN $5.23
- MVBF $27.49
- Technical
- Relative Strength Index (RSI)
- PGEN 49.47
- MVBF 55.96
- Support Level
- PGEN $3.86
- MVBF $25.12
- Resistance Level
- PGEN $4.35
- MVBF $26.79
- Average True Range (ATR)
- PGEN 0.27
- MVBF 0.77
- MACD
- PGEN -0.04
- MVBF -0.02
- Stochastic Oscillator
- PGEN 23.33
- MVBF 59.07
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.